The Readout Loud
by STAT
November 8, 2024 7:54 am
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Recent Episodes
330: How a Trump presidency could affect the FDA, the biotech industry, and its stocks
1 week ago329: Lilly's earnings surprise, investors mull the election, & a spooky ghost story
2 weeks ago328: Pfizer's activist troubles, gene therapy questions, RFK Jr.'s MAHA ambitions
3 weeks ago327: Biotech's next gold rush, GLP-1 shortages, and STAT Summit highlights
4 weeks ago326: Crypto for CRISPR, a new RNAi startup, & a Nobel for AI
1 month ago325: Biden's health care AI czar, a new obesity company, and its dealmaking CEO
1 month agoFrom Tradeoffs: Race to the Bottom
2 months ago324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug
2 months ago323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
2 months ago322: A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids
2 months ago